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Introduction
▼
Skeletal muscle injuries are the most common 
sports-related injuries (their frequency varying 
from 10–55 % of all sustained injuries) and a 
major concern in sports medicine [2, 19]. Accord-
ing to the World Health Organization (WHO), 
musculoskeletal injuries are the most common 
cause of severe long-term pain and physical dis-
ability, and affect hundreds of millions of people 
worldwide [38]. Loss or abnormality of bodily 
structure or functioning resulting from an iso-
lated exposure to physical energy during sports 
training or competition are normally diagnosed 
by a clinical professional as a medically recog-
nized injury [33].
In human sport clinics, the diagnosis of muscle 
injury is adequate in most cases, but imaging 
modalities such as ultrasonography, computed 
tomography (CT) or magnetic resonance imaging 
(MRI) are important to differentiate between 
structural lesions and functional disorders and to 
determine the extent of the injury although 
small and deep hematomas localized within the 
muscle belly could be more difficult to diagnose 
clinically [1, 23, 32]. Ultrasonography can be con-
sidered a valid first-line tool, if a more exact 
characterization of the injury is desired. MRI, in 
turn, should be preferred if a clear discrepancy 
exists between the patient’s symptoms, the phy-
sician’s findings and/or the ultrasonography and, 
in particular, in injuries close to the muscle-ten-
don junction [1, 32], where MRI has shown its 
superiority over ultrasonography [18]. MRI can 
accurately confirm or rule out the existence of 
muscle injury and also provides a very detailed 
characterization of the muscle lesion [18]. At pre-
sent, there is much controversy in the classifica-
tion of skeletal muscle injuries, which sometimes 
causes limitations to the comprehensive study of 
muscle injuries and discrepancies in the uni-
formity for their categorization and description 
[10]. Based in the last classification proposed by 
Pollock et al. [27], skeletal muscle lesions could 
be classified in 4 grades depending on MRI imag-
ing: a) Grade I: These are small injuries of the 
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Abstract
▼
Skeletal muscle injuries are the most common 
sports-related injuries in sports medicine. In this 
work, we have generated a new surgically-
induced skeletal muscle injury in rats, by using a 
biopsy needle, which could be easily reproduced 
and highly mimics skeletal muscle lesions 
detected in human athletes. By means of histol-
ogy, immunofluorescence and MRI imaging, we 
corroborated that our model reproduced the 
necrosis, inflammation and regeneration pro-
cesses observed in dystrophic mdx-mice, a model 
of spontaneous muscle injury, and realistically 
mimicked the muscle lesions observed in profes-
sional athletes. Surgically-injured rat skeletal 
muscles demonstrated the longitudinal process 
of muscle regeneration and fibrogenesis as stated 
by Myosin Heavy Chain developmental (MHCd) 
and collagen-I protein expression. MRI imaging 
analysis demonstrated that our muscle injury 
model reproduces the grade I-II type lesions 
detected in professional soccer players, including 
edema around the central tendon and the typi-
cally high signal feather shape along muscle fib-
ers. A significant reduction of 30 % in maximum 
tetanus force was also registered after 2 weeks of 
muscle injury. This new model represents an 
excellent approach to the study of the mecha-
nisms of muscle injury and repair, and could 
open new avenues for developing innovative 
therapeutic approaches to skeletal muscle regene-
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muscle characterized by high signal change (edema in T2), which 
is evident at this site and extends over a limited area of less than 
5 cm and less than 10 % of the muscle cross-sectional area at its 
maximal site; b) Grade II: These types of injuries are moderate 
injuries of the muscle. Under MRI imaging, the high signal 
change will either measure between 10 and 50 % of the cross-
sectional area of that individual muscle at the site of injury or 
extend between 5 and 15 cm within the muscle. Architectural 
fiber disruption is commonly less than 5 cm; c) Grade III: These 
injuries are extensive injuries of the muscle. MRI features of high 
signal change patterns of greater than 50 % of the muscle cross-
sectional area or greater than 15 cm in length. It is evidenced 
that the architectural muscle fiber disruption which is likely to 
be greater than 5 cm; d) Grade IV: These are the most severe 
injuries and are characterized by a complete tear of either the 
muscle or tendon.
Skeletal muscle lesions are often caused by eccentric contraction 
that forcibly lengthens an activated muscle. When unaccus-
tomed or intense, this active stretching of the muscle-tendon 
unit can produce exercise-induced muscle injury [7]. Clinical 
data reveal a high recurrence rate (nearly 30 %) of skeletal muscle 
strain injuries among professional athletes [37], and a main con-
cern in professional athletes is the faster recovery after trauma 
[4]. The consequences of failed treatment can be very dramatic, 
possibly postponing an athlete’s return to play for weeks or even 
months. Thus the recognition of some basic principles of skeletal 
muscle regeneration and healing processes can considerably 
help in both avoiding the imminent dangers and accelerating the 
return to competition [17].
Adult skeletal muscle has the ability to self-repair in response to 
injury [6, 13] and commonly the muscle tissue is damaged and 
repaired repeatedly throughout life, especially in sportsmen. 
The natural history of muscle injury proceeds through a highly 
coordinated sequence of steps. Muscle regeneration is a highly 
coordinated process that requires the utilization of undifferenti-
ated cells, called satellite cells (or myogenic progenitor cells) 
located between the basal lamina and the sarcolemma of mature 
muscle fibers [3, 9, 13, 31]. Satellite cell population is a residual 
pool of self-renewing progenitor cells, capable of supporting 
additional rounds of regeneration and to reestablish the initial 
quiescent satellite cell’s pool after every muscle injury episode 
[8]. When activated by muscle damage, they can proliferate pro-
ducing a large number of myoblasts that can repair skeletal mus-
cle injury and generate a large number of new myofibers within 
just a few days [36]. Myoblasts can fuse and differentiate into 
multinucleated fibers recapitulating the events of embryonic 
muscle development and finally restoring the skeletal muscle 
architecture [6, 13, 25, 28, 31]. The complex muscle repair pro-
cess is dependent on an orchestrated response between the 
inductive signals of cytokines and growth factors, which are 
released by the injured fibers, invading macrophages and inflam-
matory cells or connective tissue [6, 9]. Simultaneously, 
increased expression of angiogenic factors and markers of new 
capillaries, such as vascular endothelial growth factor (VEGF), 
angiopoeitin-1/2 and α-smooth muscle actin (α-SMA), could be 
detected along with the formation of new myofibers ensuring 
the maintenance of blood supply to regenerated muscle [30, 35].
The repair of skeletal muscle follows a set pattern, which can be 
divided into 3 phases [15, 16, 18, 19, 21]: 1) Destruction phase, 
characterized by the rupture of the membrane of muscle fibers 
and the subsequent necrosis and inflammatory cell reaction; 2) 
Repair phase, characterized by the phagocytosis of the necrotic 
muscle fibers by blood derived monocytes, satellite cells activa-
tion, generation of new muscle fibers and the production of a 
tissue scar; 3) Remodeling phase, characterized by the reorgani-
zation of the muscle fibers, the remodeling of the scar tissue, and 
the restoration of muscle function and maturation of the regen-
erating myofibers including the formation of a mature contrac-
tile apparatus. Even though in the last 25 years extensive 
research has been directed towards the elucidation of the pro-
cess of skeletal muscle regeneration, its complex regulatory 
pathways still remain poorly understood [22].
In this study, we present a new in vivo model of surgically-
induced lesions that could mimic the most frequent skeletal 
muscle lesions observed in the human sports clinics. Hence, in 
the present work our aim was to generate a new surgically-
induced skeletal muscle injury model in rats that could be easily 
reproduced and that mimicked the skeletal muscle lesions 
observed in human elite athletes and sportsmen which could 
open new avenues for future studies of innovative therapeutic 




Adult (8-week-old) male Wistar rats (Harlan Laboratories, Indi-
anapolis, IN) were used as animal model. The total number of 
animals used in our study was 63. Rats were housed at 22–24 °C 
and maintained on a 12-h light/dark cycle. Water and food were 
given ad libitum during the experiments. All procedures were 
performed in accordance with Spanish (Real Decreto 53/2013) 
and European (2010/63/UE) legislation and approved by the 
Departament d’Agricultura, Ramaderia, Pesca, Alimentació i Medi 
Natural of the Catalan Government (Generalitat de Catalunya).
Surgically-induced skeletal muscle injury rat model
Rats were anaesthetized by an intraperitoneal injection of a 
mixture of ketamine (75 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.) 
before surgical procedure and placed in prone position by the 
fixation of tail and extremities with adhesive strips to a cork sur-
face exposing the ventral side of the right crus. The surgical pro-
cedure for creating skeletal traumatic muscle lesion in the rat 
gastrocnemius muscle is illustrated in  ●▶ Fig. 1. The muscle injury 
was generated by using an 18 g biopsy needle (Bard® Monopty® 
Disposable Core Biopsy Instrument, Bard Biopsy Systems, 
Tempe, USA) with 0.84 mm inner diameter. Transversal biopsy 
procedure was performed at the myotendinous junction level of 
the right leg medial gastrocnemius muscle (3 mm from the start 
of muscle-tendon junction and 2 mm in depth) after shaving the 
lower extremity and cleaning with ethanol to identify the white 
Achilles tendon and measure the injury site from the muscle-
tendon junction site. Post-surgical analgesia (buprenorphine 
0.01 mg/kg) was subcutaneously administered to all operated 
animals. Our study conforms to the ethical standards in sport 
and exercise science research [12].
Measurement of muscle injury size in rat medial 
gastrocnemius muscle
The size of the muscle lesion caused by the biopsy needle in the 
medial gastrocnemius muscle was measured by measuring the 
areas in Hematoxylin-Eosin histology images from rat gastroc-
nemius muscle sections (N = 5 for each time-point) at 1, 3, 5, 7, 
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obtained by using a BX-61 microscope (Olympus) equipped with 
a DP72 camera (Olympus) and the CellSens® Digital Imaging 
software (version 1.9). The areas of the injured muscle region 
and the total medial gastrocnemius were quantified by using the 
Image J v1.46 software. The size of the muscle lesion was repre-
sented by the percentage of the injured area vs. the total area of 
the medial gastrocnemius muscle.
Histology	and	immunofluorescence	analysis
Animals (N = 5 for each time point) were euthanized by intra-
peritoneal injection of an overdose of ketamine (75 mg/kg) and 
xylazine (10 mg/kg) at 1, 3, 5, 7, 10, 12, 14, 18, 21 and 26 days 
after the injury. Gastrocnemius muscles were excised, and 
immediately frozen in 2-methylbutane (Alfa Aesar. A Johnson 
Matthey Company, Karlsruhe, Germany), which was previously 
super-cooled in liquid nitrogen, and stored at -80ºC until analy-
sis. Frozen medial gastrocnemius were transversely sectioned 
(10 µm thick) using a Cryotome (Leica Microsystems, Wetzlar, 
Germany) at below − 20 °C and mounted on PolylisineTM glass 
slides (VWR, Leuven, Belgium). Consecutive frozen muscle sec-
tions were used for histological and immunofluorescence analysis.
For histological analysis, rat skeletal muscle sections were 
stained with Hematoxylin-Eosin (1 min hematoxylin and 15 s 
eosin), washed in water, dehydrated with graded ethanol solu-
tions (1 min ethanol 50 %, 1 min ethanol 70 % twice, 1 min etha-
nol 90 %, 1 min ethanol 100 % twice) and cleared in xylene (5 s). 
After air-drying for 5 min, the slides were mounted with DPX 
mounting medium and a coverslip (VWR, Madrid, Spain). Hema-
toxylin Harris solution was purchased from Casa Álvarez (Casa 
Álvarez, Madrid, España) and eosin solution was prepared by 
dissolving 0.5 g Eosin Yellowish (Panreac Quimica SA, Barcelona, 
Spain) in 100 ml water with 200 μl glacial acetic acid (Sigma-
Aldrich Quimica SA, Madrid, Spain). Ethanol absolute and xylene 
were obtained from VWR (VWR, Leuven, Belgium).
For immunofluorescence analysis, frozen muscle sections were 
fixed in cold ( − 20 °C) acetone (Sigma-Aldrich Quimica SA, 
Madrid, Spain) for 5 min, air-dried and blocked in PBS containing 
3 % BSA (bovine serum albumin, Sigma-Aldrich Quimica SA, 
Madrid, Spain) for 10 min at room temperature and then incu-
bated with primary antibodies diluted 1:100 in PBS (Phosphate 
buffered saline, Biowest, Barcelona, Spain). The primary anti-
bodies used were against rabbit anti-Collagen I (Abcam, 
 Cambridge, UK), mouse α-smooth muscle actin (α-SMA) (Sigma-
Aldrich Quimica SA, Madrid, Spain) and mouse developmental 
Myosin Heavy Chain (MHCd, Novocastra, Newcastle, UK) for 16 h 
in a humid chamber at 4 °C. Samples were washed 3 times in PBS 
and incubated with the secondary antibodies Alexa Fluor® 568 
anti-mouse or Alexa Fluor® 488 anti-rabbit (Invitrogen, Oregon, 
USA) diluted 1:1000 in PBS in a dark humid chamber for 1 h at 
room temperature. Finally, slides were washed 3 times with PBS 
and mounted using a coverslip and Fluoromount-G (Southern Bio-
tech, Madrid, Spain) mounting medium. Fluorescence was evalu-
ated by using a BX-61 microscope (Olympus) using a DP72 camera 
(Olympus) and CellSens® Digital Imaging software (version 1.9).
Imaging studies by Magnetic Resonance (MRI)
In vivo 1H-magnetic resonance imaging (MRI) studies were per-
formed daily during 4 weeks at the NMR facilities of the Autono-
mous University of Barcelona (UAB, Barcelona, Spain) using a 7 T 
Bruker BioSpec 70/30 USR (Bruker BioSpin GmbH, Ettlingen, 
Germany) system equipped with a mini-imaging gradient set 
(400 mT/m) and using a quadrature transceiver volume coil with 
72 mm inner diameter.
Rats (N = 3) were positioned in a bed, which allowed delivery of 
anesthesia (isoflurane, 1.5–2.0 % in O2 at 1 L/min), with an inte-
grated heat water circuit for body temperature regulation. Body 
temperature was measured with a rectal probe and maintained 
at 37 ± 1 °C. Respiratory frequency was monitored with a pres-
sure probe and kept between 60–80 breaths/min. Low resolu-
tion T2-weighted fast spin-echo images were initially obtained 
in axial, sagittal and coronal planes to be used as reference scout 
images. Imaging parameters for these images were: effective 
echo time (TEeff) = 36 ms; repetition time (TR) = 3 s; echo train 
length (ETL) = 8; field of view (FOV) = 6 × 6 cm2; matrix size 
(MTX) = 128 × 128; slice thickness (ST) = 2 mm; gap between 
slices (gap) = 0.5 mm; number of slices (NS) = 25 -axial, 10 -sagit-
tal, 11 -coronal; number of averages (NA) = 1. High resolution 
T2-weighted fast spin-echo images were acquired afterwards in 
axial, sagittal and coronal planes containing the lesion and 
the contralateral side. Experimental parameters for these 
images were: TEeff = 25 ms; TR = 4 s; ETL = 4; FOV = 6 × 6 cm2; 
MTX = 512 × 256 – for axial and coronal sections and 256 × 256 
for sagittal sections; ST = 1 mm; gap = 0.1 mm; NS = 35 -axial and 
coronal, and 32 -sagittal; NA = 4 -axial and coronal, 2 -sagittal; 
experimental time  = 12 min 48 s for axial and coronal images 
and 6 min 24 s for sagittal images. MRI data were acquired and 
processed on a Linux computer using Paravision 5.1 software 
(Bruker BioSpin GmbH, Ettlingen, Germany).
Analysis of rat medial gastrocnemius muscle force
The maximum tetanus force (TetF) of the gastrocnemius muscle 
was analyzed in rats (N = 8) anesthetized by an intraperitoneal 
injection of a mixture of ketamine (75 mg/kg, i.p.) and xylazine 
Fig. 1 Surgically-induced skeletal muscle injury rat model. a Male 
Wistar rats were used as the animal model for muscle injury induction 
using the automatic biopsy needle. b Animals were anaesthetized before 
surgical procedure and placed in prone position by the fixation of tail 
and extremities. c Skeletal muscle injury was generated by using an 18 g 
biopsy needle (Bard® Monopty® Disposable Core Biopsy Instrument, Bard 
Biopsy Systems, Tempe, USA). d Transverse biopsy procedure in medial 
gastrocnemius muscle was generated by using the biopsy needle at 3 mm 
proximal from the muscle-tendon junction site. e The lesion spans roughly 
50 % of the cross-sectional area of the medial gastrocnemius muscle.  
f After biopsy, needle was extracted and external antiseptic was applied. 
Post-surgical analgesia was subcutaneously administered to all operated 
animals. g One week after surgery the puncture wounds created from the 
entrance and exit of the biopsy needle were closed.
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(10 mg/kg, i.p.). Anesthetized animals were placed in prone posi-
tion in a platform with the knee placed in fully extended posi-
tion and fixed with 2 needles (one in the knee and the other in 
the ankle) in order to immobilize the limb. Achilles tendon 
including the calcaneus was separated from the surrounding tis-
sue leaving the proximal origin, blood supply and nerves intact. 
The Achilles tendon was cut and attached, by using a tendon 
hook stretched with a passive force of 100 mN, to a force trans-
ducer (TRI-201 Letica Scientific Instruments, Barcelona, Spain) 
connected to a polygraph (Polygraph 2006; Letica Scientific 
Instruments, Barcelona, Spain). The sciatic nerve was then 
exposed through a lateral incision on the thigh and connected to 
an electrode and a stimulator (Universal Kimograph; Harvard 
Apparatus, Holliston, Massachusetts, USA). Muscle force analysis 
was conducted at a constant room temperature of 25–27 °C, and 
the gastrocnemius muscle was covered with mineral oil to pre-
vent muscle drying during the muscle force determination. The 
TetF was measured by electrical stimulation of sciatic nerve at a 
frequency of 100 Hz, 0.1 ms pulse width and a voltage of 5 V. For 
each animal, TetF was determined both in the control (non-
injured) left gastrocnemius muscle and the injured right leg gas-
trocnemius muscle.
Statistical analysis
The statistical analysis was performed using IBM SPSS Statistics 
version 20.0 (IBM; Armonk, New York, United States). Maximum 
tetanus force values were normalized to the individual gastroc-
nemius muscle mass (represented by the TetF divided by the 
muscle weight and expressed in mN/g).
The normality and homoscedasticity of data were studied for 
each parameter to apply the correct statistical methods (para-
metric or non-parametric). The Kolmogorov-Smirnov test was 
used to verify the normal distribution of the data.
Data showed a normal distribution and paired Student’s t test 
were used to compare statistical differences in maximal muscle 
force between animal.
The power analysis for the t-paired test was automatically per-
formed to detect a minimum difference in means of 0.8 and with 
and alpha value of 0.05. Differences were considered statistically 
significant when P < 0.05. The results are presented as mean ± SD.
Results
▼
Analysis of surgically-induced muscle injury size in rat 
medial gastrocnemius muscle
The size of the muscle injured area caused by the biopsy needle 
( ●▶ Fig. 1) was evaluated in H-E stained muscle sections at 1, 3, 5, 
7, 14, 21, 26, 35 and 46 days post-injury ( ●▶ Fig. 2). Both injured 
muscle area and the total area of medial gastrocnemius muscle 
were quantified by using the Image J v1.46 software after mark-
ing out both the specific injured area and the total area of medial 
gastrocnemius muscle ( ●▶ Fig. 2a). As shown in  ●▶ Fig. 2b, the 
surgically-induced muscle injury with the biopsy needle caused 
a lesion in the rat medial gastrocnemius of 30.0 ± 5.9 % of the 
total transversal area of the muscle just 24 h post-injury, being at 
this time-point when the injured area reached its maximum 
size. From this time on, the measured size values of the injured 
area decreased progressively until the day 46 post-injury (at the 
end period of muscle regeneration process) when was approxi-
mately the 2 % of the total area of medial gastrocnemius muscle.
Histological analysis of skeletal muscle injury 
longitudinal evolution
By means of H-E stain ( ●▶ Fig. 3), we corroborated that the histo-
logical changes in our rat model of skeletal muscle injury highly 
reproduced the necrosis and regeneration processes observed in 
other animal models of induced muscle injury [11, 26, 39] or ani-
mal models of spontaneous skeletal muscle injury, such as the 
dystrophic mdx-mice [22]. As a result, 12–24 h after surgically-
induced injury our rat animal model showed the presence of 
necrotic fibers and edema with some infiltrating inflammatory 
cells and macrophages. This was followed by an inflammatory 
phase (1–3 days post-injury) were the injured area was exten-
sively invaded by macrophages and inflammatory cells and an 
ensuing regenerative phase in which small diameter, newly 
formed, regenerating basophilic fibers started to appear (3–5 
days post-injury). From 5–7 days post-injury, new formed baso-
philic fibers progressively grew in the injured area concomi-
tantly with the progressive withdrawal of the inflammatory cells 
(7–14 days post-injury). 3 weeks after surgically-induced injury, 
muscle damaged tissue was completely replaced by the new 
muscle fibers. From 26 days after injury, the tissue showed a 
fully regenerated aspect with the presence of centrally-nuclei 
muscle fibers and the absence of inflammation-related cells. 
Finally, 46 days post-injury the tissue showed normal character-
istics and completely regenerated structure.
Fig. 2 Quantification of the size of the lesion induced by the biopsy-
needle in the rat model. The size of the muscle injured area caused by the 
biopsy needle was evaluated in H-E stained rat (N = 5 for each time-point) 
muscle transversal sections at 1, 3, 5, 7, 14, 21, 26, 35 and 46 days 
post- injury. a Representative image (14 days post-injury) of the muscle 
H-E stained sections used for measurement of the size of the injury. 
Both injured muscle area and the total area of medial gastrocnemius 
(MG) muscle were marked out and quantified by using the Image J v1.46 
software. b The percentage of the injured muscle respecting to the total 
medial gastrocnemius muscle area was measured. Values are presented 
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Immunofluorescence	analysis	of	skeletal	muscle	injury	
longitudinal evolution
In order to determine the muscle regeneration and fibrogenesis 
experienced in our rat model of skeletal muscle injury, we per-
formed a study by immunofluorescence ( ●▶ Fig. 3) to analyze, on 
the one hand, the expression levels of the developmental/
embryonic form of myosin heavy chain (MHCd), a well-known 
marker for muscle development [21, 22] and adult muscle regen-
eration after injury [22] and, on the other hand, the levels of the 
fibrosis marker collagen-I and the angiogenesis marker α-SMA, 
which stains for the smooth muscle layer of blood vessels and 
capillaries [14].
MHCd was analyzed during muscle necrosis and regeneration 
process by immunofluorescence. In adult muscle MHCd is only 
expressed during muscle regeneration after injury and in the 
first period of myofiber formation until its replacement by the 
mature isoforms (fast or slow) myosin heavy chains. In our skel-
etal muscle injury model, MHCd levels were undetectable dur-
ing the first days post-injury. MHCd started to appear 3 days 
after the lesion and showed a progressive increase, reaching its 
maximum levels of expression around 7–9 days post-injury. 
From this time on, corresponding to the last phases of muscle 
regeneration and myofiber differentiation, MHCd expression 
decreased gradually to be undetectable beyond 26 days after 
muscle injury.
We also analyzed the expression levels of the fibrotic marker 
collagen-I during all the process of muscle regeneration after 
injury. Collagen-I, detected specifically surrounding the fibers’ 
perimeter in non-injured muscle fibers, strongly increased its 
expression and deposition in injured areas just after the muscle 
lesion was created and persisted during the inflammatory and 
regeneration periods. Collagen-I showed a prompt and strong 
increase from the first days post-injury, demonstrating an abun-
dant deposition in injured areas from day 3 post-injury and 
reaching its maximum levels around 7–9 days after injury. From 
day 14 post-injury, and coinciding with the presence of newly 
formed myofibers, collagen-I started to decrease progressively 
but its presence was still detectable 35 days after muscle lesion 
forming a scar-like tissue clearly visible following the direction 
were the lesion was created by crossing the muscle from side to 
side. The α-SMA staining demonstrated the increase in the num-
ber of capillaries, specially in regenerating areas, from day 9 up 
to 21 post-injury where the new fibers are growing to regener-
ate the muscle tissue and the requirement of blood supply is 
increased ( ●▶ Fig. 3).
MRI analysis of the longitudinal evolution of skeletal 
muscle injury
We performed a longitudinal study of the lesion in the rat model 
by analyzing the evolution of skeletal muscle injury by using 
high resolution MRI either in the axial, coronal or sagittal planes. 
As shown in  ●▶ Fig. 4, the surgically-induced muscle injury pro-
duced a myotendinous break with retraction and gap. This mus-
Fig. 3 Histologic and immunofluorescence analysis of the longitudinal 
evolution of skeletal muscle injury in the rat model. Representative im-
ages (N = 5 for each time-point) show Hematoxylin-Eosin stained sections 
(upper panel) and immunofluorescence analysis for collagen-I/αSMA (mid 
panel) and MHCd expression (lower panel) at different times (0 and 6 h 
and 1, 3, 5, 7, 9, 14, 21, 26, 35 and 46 days post-injury) after the genera-
tion of surgically-induced medial gastrocnemius muscle injury in rats. 
Images show (× 100) microphotographs for all panels.
0 hour 6 hour 1 day 3 days 5 days 7 days
9 days 14 days 21 days 26 days 35 days 46 days
Fig. 4 In vivo MRI imaging analysis of the longitudinal evolution of skel-
etal muscle injury in the rat model. Representative images (N = 3) show 
coronal (upper panel), sagittal (mid panel) and axial (lower panel) planes 
of the in vivo 1H-magnetic resonance imaging (MRI) studies performed 
at different times (1, 3, 5, 7, 10, 12, 15, 18, 21 and 26 days post-injury) 
after medial gastrocnemius muscle surgically-induced injury in rats. Both 
edema around central tendon and the typical high signal feather shape, 
which is characteristic of grade I-II muscle lesions in human athletes, was 
clearly visible from the first day post-injury. MRI studies were carried out 
by using a 7T Bruker BioSpec 70/30 USR (Bruker BioSpin GmbH, Ettlingen, 
Germany) system equipped with a mini-imaging gradient set (400 mT/m) 
and using a quadrature transceiver volume coil with 72 mm inner diam-
eter. Experimental parameters for these images are indicated in Methods 
section. MRI data were acquired and processed on a Linux computer using 
Paravision 5.1 software (Bruker BioSpin GmbH, Ettlingen, Germany).
1 day
12 days 15 days 18 days 21 days 26 days
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cle lesion caused a strong edema which was clearly detected at 
24 h post-injury and localized around the central tendon. 
Remarkably, we observed the typical high signal feather shape, 
which is characteristic of the most frequently observed grade 
II-III muscle lesions in elite athletes. From this point on, edema 
progressively decreased until it was practically undetectable at 
26 days post-injury.
Surgically-induced skeletal muscle injury in rat model 
mimics muscle lesions observed in human elite athletes
Next, we evaluated the similarities of the surgically-induced 
lesion created in our rat model with those observed in profes-
sional athletes by comparing the MRI images obtained in rats 
with MRI images from elite soccer players. As shown in  ●▶ Fig. 5, 
we demonstrated that our muscle injury model in rats highly 
reproduced the human lesions observed in professional athletes. 
In our rat model, the surgically-induced skeletal muscle injury 
caused a typical grade I-II lesion ( ●▶ Fig. 5a), which was highly 
comparable to the grade I and grade II lesions observed in the 
proximal long head biceps femoris of a 21 years-old and in the 
proximal head biceps of a 23 years-old male professional foot-
ballers, respectively ( ●▶ Fig. 5b, c). The muscle injury in the rat 
model caused an important edema and “feathery high signal” 
along skeletal muscle fibers which is typical of these types of 
injuries in professional athletes and highly mimicked the hyper-
intensity area of edema in form of feather representative of 
grade I lesions and the hypertensity area of edema, with gap and 
retraction were the tendon is commonly involved typical of 
grade II muscle injuries.
Muscle force decrease after surgically-induced skeletal 
muscle injury
The maximum tetanus force was measured 2 weeks after muscle 
injury both in control and in injured medial gastrocnemius mus-
cles of each rat. As shown in  ●▶ Fig. 6, injured muscles showed a 
significant decrease of the 29.1 % (P = 0.001) in the maximum 
contraction force demonstrating the efficacy of our new muscle 
injury approach in skeletal muscle force reduction. The mean 
values of TetF in control muscles and injured muscles were 
643 ± 163 and 456 ± 107 mN/g, respectively.
Discussion
▼
In this study, we present a new animal model of surgically-
induced skeletal muscle injury in rats, which is easy to repro-
duce and closely mimics the muscle lesions observed in human 
elite sportsmen. The new in vivo model of skeletal muscle injury 
will be helpful for researchers in the fields of skeletal muscle 
injuries and regeneration, as well as for the in vivo testing of new 
therapeutic approaches to prevent or ameliorate muscle lesions. 
By using our newly established technical approach of surgically-
induced skeletal muscle injury, we were able not only to deter-
mine the size of the injury and all the histological and molecular 
changes in the muscle necrosis-regeneration process by histol-
ogy and immunofluorescence but also to corroborate the simi-
larities of our muscle injury rat model with the muscle lesions 
observed in professional athletes by using MRI imaging analysis. 
Furthermore, we evaluated the decrease in the medial gastroc-
nemius muscle force caused by the muscle injury in the rat 
model, in order to assess the impact on muscle strength related 
to surgically-induced lesions.
The evolution of the muscle injury induced by the biopsy needle 
in the rat skeletal muscle was evaluated by H-E staining, immu-
nofluorescence analysis of muscle regeneration and fibrosis 
markers, such as MHCd and Collagen-I, and MRI-based in vivo 
imaging analysis. By means of H-E stain ( ●▶ Fig. 3), we corrobo-
rated that the histological changes in our rat model of skeletal 
muscle injury highly reproduced the necrosis, inflammation and 
regeneration processes observed in animal models of spontane-
ous skeletal muscle injury, such as the dystrophic mdx-mice 
[22]. We demonstrated that the surgically-induced muscle 
injury followed the same orchestrated process of skeletal muscle 
Fig. 5 MRI in vivo imaging of skeletal muscle lesion comparison 
between surgically-induced rat muscle injury model and human elite 
athletes. a Coronal T2 MRI image of a 2-month-old rat 24 h after injury in 
the medial gastrocnemius muscle. Image shows the edema and “feathery 
high signal” along the muscle fibers typical of these muscle injuries in hu-
man professional athletes. b Coronal T2 MRI image of the proximal rectus 
femoris of a 21-year-old male professional footballer showing a Grade I 
injury. Image shows small hyper intensity area of edema in feather-like 
shape. c Coronal T2 MRI image of the proximal head biceps showing a 
Grade II injury of a 23 year-old male professional footballer. Image shows 




Fig. 6 Measurement of muscle strength in the surgically-induced 
muscle injury rat model. Maximum tetanus force (TetF) was measured in 
rats (N = 8) after 2 weeks of surgically-induced muscle injury. TetF values 
were normalized to medial gastrocnemius muscle weight for the control 
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regeneration after injury. In this sense, we analyzed the expres-
sion of MHCd, a well-known marker of muscle regeneration and 
the formation of new fibers in adult muscle [22, 29], which 
showed a similar pattern of expression than those detected in 
spontaneous muscle lesions in dystrophic animals [22]. MHCd 
expression increased from 3 to 14 days, indicating the presence 
of numerous newly formed regenerating fibers in the damaged 
area and then progressively disappears, becoming undetectable 
21 days after injury coinciding with the maturation phase of 
regenerated fibers. On the other hand, we analyzed the possible 
intramuscular fibrosis induced in our model by determining the 
presence of the fibrotic marker type-I collagen. Type-I collagen 
expression showed a strong increase in the injured area from 
day 3 to day 9 after muscle damage. Beginning from day 14 post-
injury type-I collagen deposition was progressively reduced, but 
a permanent scar-like type-I collagen positive extracellular 
matrix accumulation could be still detected one month after 
muscle lesion was created ( ●▶ Fig. 3). Muscle healing in sports-
derived skeletal muscle injuries is commonly followed by scar 
tissue formation after injury [34]. Intramuscular scarring often 
represents an important sequel derived from muscle injuries in 
human athletes provoking muscle weakness and increasing the 
probability of muscle re-injury. Our skeletal muscle injury-
model therefore represents a useful approach to studying such 
measures as innovative therapeutic approaches to reduce the 
fibrous tissue accumulation or scarring prevention, by testing 
anti-fibrotic agents such as Suramin, a TGF-β1 antagonist which 
has demonstrated its ability to reduce fibrous scar formation in 
muscle and enhance muscle strength in strain-injured skeletal 
muscle [5], or CAR-decorin, a potent inhibitor of scar formation 
by neutralization of both growth factors responsible for scarring, 
TGF-β1 and -β2 isoforms [20].
Since most of the human lesions related to sports are often eval-
uated by non-invasive imaging techniques such as MRI, we per-
formed a longitudinal study in order to evaluate the progression 
of the disease and to compare our findings with the most com-
mon injuries detected in skeletal muscle of elite athletes. 
Remarkably, the comparison of the MRI analysis of the lesions 
caused by our surgical approach in rats showed a strong homol-
ogy to grade I-II type lesions observed in elite soccer players 
( ●▶ Fig. 5). Both edema and the feather-like shape was very simi-
lar between our rat model and elite soccer players after 24 h of 
skeletal muscle injury. As observed in human athletes, the surgi-
cally-induced muscle injury in rats showed a strong edema 24 h 
after muscle damage, which was slowly and progressively re-
absorbed throughout the following weeks.
We also performed an analysis of the muscle force of rat skeletal 
muscle after injury, in order to determine the reduction in mus-
cle strength after muscle injury in our rat model due to biopsy 
needle-induced muscle lesion. The measurement of the TetF 
demonstrated a decrease of approximately 30 % of the total 
medial gastrocnemius muscle force 2 weeks after injury ( ●▶ Fig. 6) 
caused by the surgically-induced injury. Our results corroborate 
previous data reported in a toxin-induced muscle injury rat 
model, where a 37 % decrease in Tetanic force was described in 
rat gastrocnemius muscle 2 weeks after injury induced by intra-
muscular bupivacaine injection [24].
In summary, this study presents a new model of surgically-
induced skeletal muscle injury in rats, which mimics the com-
plete process of necrosis and regeneration observed in muscle 
injuries and reproduces very closely the most frequent skeletal 
muscle lesions observed in sports human clinics. This reproduc-
ible experimental animal model allows not only for the study of 
the complex regulatory pathways involved in the skeletal muscle 
degeneration-regeneration process but also opens new avenues 
for reliable assessment of the efficacy of both stem cell-based 
and pharmacological therapeutic approaches aimed at enhanc-
ing muscle tissue repair and preventing fibrosis and other 
adverse effects in sports-related skeletal muscle injuries.
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